Edition:
United States

Luminex Corp (LMNX.OQ)

LMNX.OQ on NASDAQ Stock Exchange Global Select Market

19.50USD
20 Sep 2017
Change (% chg)

$-0.04 (-0.20%)
Prev Close
$19.54
Open
$19.52
Day's High
$19.72
Day's Low
$19.47
Volume
42,112
Avg. Vol
73,139
52-wk High
$23.61
52-wk Low
$17.65

Chart for

About

Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company's products are focused on the molecular diagnostic testing market, which includes human genetics, personalized medicine and infectious disease... (more)

Overall

Beta: 0.27
Market Cap(Mil.): $861.15
Shares Outstanding(Mil.): 44.07
Dividend: 0.06
Yield (%): 1.23

Financials

  Industry Sector
P/E (TTM): -- 178.13 16.25
EPS (TTM): -- -- --
ROI: -- 9.49 14.87
ROE: -- 14.72 13.89

BRIEF-Luminex Corp - Labcorp agrees to extend commitment to Luminex Cystic Fibrosis

Sept 12 Laboratory Corporation Of America Holdings

Sep 11 2017

BRIEF-Zicom Group updates on litigation against Curiox Biosystems Inc​

* ‍Luminex Corporation has filed an original complaint against Curiox Biosystems Inc​

Sep 04 2017

BRIEF-Luminex Corporation Q2 earnings per share $0.13

* Luminex Corporation reports second quarter 2017 financial results

Aug 07 2017

BRIEF-Luminex Corporation receives FDA clearance for ARIES C. difficile assay

* Luminex Corporation receives FDA clearance for ARIES C. difficile assay

Jul 24 2017

BRIEF-Luminex Verigene gram-positive and gram-negative blood culture panels get reimbursement approval in Japan

* Luminex Corporation's verigene gram-positive and gram-negative blood culture panels receive reimbursement approval in Japan

Jun 05 2017

BRIEF-Luminex Corp Q1 gaap earnings per share $0.21

* Luminex Corp says Q1 total Verigene related revenue of $10.5 million; growth of 59% over its Q1 2016

May 01 2017

Earnings vs. Estimates